Persistent antibody depletion after rituximab in three children with autoimmune cytopenias. (Q54423024)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19954366%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

title

Persistent antibody depletion after rituximab in three children with autoimmune cytopenias (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19954366%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19954366%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

Brian H Eichner

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19954366%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Courtney Thornburg

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19954366%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Larry Williams

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19954366%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

publication date

1 November 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19954366%20AND%20SRC:MED&resulttype=core&format=json

Pediatric Hematology and Oncology

13 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19954366%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19954366%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19954366%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

566-572

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19954366%20AND%20SRC:MED&resulttype=core&format=json

Rituximab inhibits the in vivo primary and secondary antibody response to a neoantigen, bacteriophage phiX174.

13 February 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08880010903271697

Treatment of childhood autoimmune haemolytic anaemia with rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880010903271697

Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880010903271697

Rituximab therapy for childhood Evans syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880010903271697

Enteroviral meningoencephalitis after anti-CD20 (rituximab) treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880010903271697

Hematologic complications of primary immune deficiencies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880010903271697

Childhood autoimmune cytopenia secondary to unsuspected common variable immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880010903271697

Immunologic responses to bacteriophage ϕX 174 in immunodeficiency diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880010903271697

Use of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880010903271697

Repeated courses of rituximab for autoimmune cytopenias may precipitate profound hypogammaglobulinaemia requiring replacement intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880010903271697